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Background. Although epidural opioids have excellent analgesic property, their side-effects
limit its use in patient-controlled epidural analgesia (PCEA). This study was designed to compare
side-effects of epidural sufentanil in ropivacaine with that of morphine in ropivacaine focusing on
lower urinary tract function after major abdominal surgery.
Methods. In total 60 patients undergoing gastrectomy were randomly allocated to receive either
sufentanil in ropivacaine (Group S, n=30) or morphine in ropivacaine (Group M, n=30) for their
PCEA. Epidural catheter was inserted between the 7th and 8th thoracic spine. Visual analogue
pain score and side-effects such as nausea, vomiting, pruritus, hypotension and urinary retention
were evaluated during postoperative days (PODs) 1 and 2 in the postanaesthetic care unit.
Results. The incidence of serious to major micturition problem in Group S was lower than that
in Group M (P<0.001). The incidence of pruritus, nausea and vomiting was also lower in Group S
than in Group M on POD 1.
Conclusions. The lower incidence of major/serious micturition problem in patients receiving
sufentanil in ropivacaine thoracic epidural analgesia suggests that continuation of urinary drainage
may not be necessary from POD 1 onwards.
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Epidural administration of opioids mixed with a local
anaesthetic has become popular in perioperative analgesia.
However, the side-effects of opioids such as respiratory
depression, itching, nausea, vomiting and urinary retention
can be major problems. In particular, their effects on lower
urinary tract function lead to routine bladder catheterization,
which increases the risk of urinary tract infection.1–3
Recently, in healthy male volunteers, intrathecal opioids
were reported to decrease bladder function by suppression
of detrusor contractility, and the recovery of normal
lower urinary tract function was significantly faster after
intrathecal sufentanil than after morphine.4 However,
pathogenesis of postoperative urinary retention is multifac-
torial, and includes the use of drugs that affect urinary
detrusor function, intraoperative damage to the pelvic auto-
nomic nerve and stress-induced activation of inhibitory
sympathetic reflexes.5–7 In addition, local anaesthetic
drugs are used for postoperative epidural analgesia to pro-
vide improved analgesia after major abdominal operations.
This study was designed to compare the side-effects of
epidural sufentanil in ropivacaine with that of morphine in
ropivacaine after a major abdominal surgery. We focused on
lower urinary tract function, thereby, assessing the optimal
duration of routine bladder catheterization in patients
undergoing gastrectomy.
Materials and methods
After obtaining approval of the institutional Ethics Com-
mittee and written informed consent, 60 ASA I–II patients
undergoing gastrectomy were recruited. Using sealed
envelope system, the patients were randomly allocated to
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one of the two groups to receive either sufentanil in
ropivacaine (Group S, n=30) or morphine in ropivacaine
(Group M, n=30) for the postoperative epidural analgesia.
Before surgery, patients were instructed on the use of the
patient-controlled epidural analgesia (PCEA) device and
visual analogue scale (VAS) pain score. Patients and anaes-
thetists were blinded to the treatment group and an inde-
pendent researcher prepared the study solution consisting of
275 ml mixture of ropivacaine 0.2%, and sufentanil 250 mg
(0.9 mg ml1) in Group S or morphine 10 mg (36 mg ml1)
in Group M.
Patients with known urological disease, spinal disease,
coagulopathy and on any medication that might have influ-
enced the sympathetic nervous system were excluded from
this study. Patients who had refused neuraxial anaesthesia
were also excluded. Patients who were to undergo surgery
in the afternoon were excluded because the indwelling
urinary catheter was to be removed in the morning of the
first postoperative day (POD 1).
All the patients were premedicated with i.m. midazolam
2 mg and glycopyrrolate 0.2 mg. Before the induction of
general anaesthesia, an epidural catheter was inserted
between the 7th and 8th thoracic spine (T7–8) and the
catheter was advanced 3 cm upwards. After a test dose of
lidocaine 2%, 3 ml with epinephrine (1:200 000), lidocaine
2%, 5 ml was given via epidural route. General anaesthesia
was induced with i.v. thiopental sodium (4 mg kg1),
fentanyl (1.5 mg kg1), and rocuronium (0.8 mg kg1).
No additional i.v. opioid agent was given after this. After
induction of anaesthesia, indwelling urinary catheter was
inserted. Anaesthesia was maintained with oxygen/air
(50:50) and sevoflurane, and vecuronium was given for
continued muscle relaxation. The end-tidal concentration
of sevoflurane was adjusted to maintain arterial blood
pressure within 20% of baseline values. Arterial blood pres-
sure below 20% of baseline was treated with boluses of
ephedrine. After induction of general anaesthesia, epidural
analgesia was started using a silicone balloon infuser
(Accufuser, Woo Young Medical Co. Ltd, Korea) contain-
ing the study solution. The balloon pump infuser lasted for
2 days; it was set to 5 ml h1 for continuous infusion and
0.5 ml for bolus dose with a 15 min lockout period. The
tracheal tube was removed in the operating theatre at the
end of surgery. In the postanaesthetic care unit (PACU), in
addition to VAS pain score, patients were evaluated for the
side-effects of epidural opioids such as nausea, vomiting,
pruritus and the incidence of hypotension by an investigator
blinded to group allocation of the patients. Motor block was
evaluated using a previously described scale (1=no motor
block, 2=knee blocked and mobility of ankle preserved,
3=mobility of ankle difficult, and 4=knee and ankle blocked)
and the sensory block level was evaluated by response to a
cold stimulus to the skin. Patients with VAS pain score
higher than 5 were given i.m. meperidine 25 mg as rescue
analgesia. In the morning of POD 1, indwelling urinary
catheter was removed. A nurse who was blinded to the
patient group recorded the incidence whenever a patient
complained of nausea, vomiting, pruritus or micturition
problem until POD 2. Motor block, sensory block and
VAS pain scores at rest and during coughing were recorded
in the morning of POD 1 and 2. Blood pressures were
measured every 6 h until POD 2. To assess micturition
problem, patients were to report the need to void, and
their urine volume whether it was <200 or >700 ml. They
were also to report lack of urge or feeling of incomplete
micturition. If the patients were unable to void 6 h after the
removal of the urinary catheter, the bladder was drained
with in-and-out catheterization and urine volume was
checked. Micturition problems were classified according
to a previously used classification by Vercauteren and
colleagues8 (Table 1) and the bladder was drained with
in-and-out or indwelling catheterization in patients with
serious or major problem, respectively. Epidural catheter
was removed after the silicone balloon infuser was empty.
In a previous study, Vercauteren and colleagues8 have
shown that low dose bupivacaine–sufentanil group reduced
the grade of micturition problem to 1.0 (SD 1.0) compared
with 1.9 (1.2) in the high dose bupivacaine–sufentanil group
on POD 1. A sample size was calculated based on this
effect, with a=0.05 and b=0.2. In total, 27 patients were
required in each group in order to detect a statistically
significant difference between the groups. A total of
30 patients were recruited in each group to compensate
for loss of data during follow-up. As there was no with-
drawal, the result of 30 patients were included in this
study. Retrospective power calculation showed the power
of this study to be 91%.
Statistical analyses were performed using the statistical
package for social sciences statistical software (SPSS 10.0,
SPSS Inc., Chicago, IL). Chi-square test, t-test,
Mann–Whitney U-test and Fisher’s exact test were used
to compare variables between the groups where appropriate.
Results are expressed as mean (SD) or number of patients.
P-value <0.05 was considered statistically significant.
Table 1 Classification of micturition problems
Minor problems
(1) Urge to void with urine volume >700 ml
(2) Report or observation (once) of either
(a) Feeling of incomplete micturition
(b) Difficult micturition but volumes >200 ml
(c) Too low volume of urine (<2 ml kg1)
Serious problems
(3) No urge to void but producing volumes >700 ml
(4) Repeated or combined observation of feeling of incomplete voiding,
difficult urination (>200 ml), and/or too low volume
Major problems, requiring bladder catheterization
(5) Incontinence
(6) Globus and inability to urinate
(7) Impossibility to void 18 h after surgery or >6 h after previous
micturition
(8) Unpleasant/painful feeling in the groin with inability to void
(9) Repeated and combined observation of feeling of incomplete voiding,
difficult urination (>200 ml), and too low volume
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Results
Patient characteristics and data from the perioperative
periods are listed in Table 2. The duration of surgery,
blood loss, urine output and amount of fluids infused
between the two groups were comparable (Table 2). The
level of the sensory block to cold stimulus ranged from
T3–T6 to T10–L2. The ranges of the level of sensory
block (upper and lower segments) were similar between
the two groups. None of the patients had motor block
(all were scale 1). The extension of sensory blockade was
not checked because patients were unable to distinguish the
level of cold sense during continuous infusion of study
mixture. There were no significant differences in VAS
pain scores at rest and during coughing between two groups
throughout the study period (Table 3). The dose of study
mixture infused was the same for all patients because the
balloon infuser was removed when the container became
empty, with an average time of 44.4 (5.4) h in Group M
and 43.3 (6.6) h in Group S.
Side-effects of epidural opioids except micturition pro-
blems are listed in Table 3. Two patients in Group M and
one in Group S were hypotensive in PACU. They were
treated with ephedrine and discharged from PACU when
the blood pressure was maintained near normal for over an
hour. The blood pressure was stable in all patients in the
ward. The incidence of pruritus was significantly higher in
Group M than that in Group S on POD 1 (P<0.05). The
incidence of nausea and vomiting was also significantly
higher in Group M than in Group S on POD 1 (P<0.05).
None of the patients had respiratory depression.
The number of patients with micturition problems is
listed in Table 4. The number of patients with serious to
major micturition problem in Group S was significantly less
than that in Group M on POD 1 and POD 2 (all P<0.001).
Throughout the study period, no patient in Group S had
any serious or major micturition problem. On the other
hand, 12 (40%) patients in Group M complained of serious
micturition problem and one patient needed indwelling
bladder catheterization because the patient produced
<200 ml urine twice, complained of incomplete voiding
sense and could not void for more than 6 h after previous
micturition. No patient had urinary problems at 30 days
follow-up.
Discussion
The results of this prospective, randomized, double-blind
study indicate that, during postoperative epidural analgesia,
compared with epidural morphine, epidural sufentanil has a
lower incidence of opioid-induced side-effects including
micturition problems that may necessitate the bladder
catheterization.
Studies on the effect of neuraxial morphine on lower
urinary tract function have shown that intrathecal morphine
suppresses bladder contraction.4 9 10 However, the exact
mechanism has not been elucidated. In 1983, Rawal and
colleagues10 reported that 2, 4 and 10 mg of epidural
morphine decreased detrusor contractility with increased
maximal bladder capacity, and that these effects were
reversed with naloxone. Intravenous or intramuscular
morphine had little effect on detrusor muscle. The authors
Table 2 Patient characteristics and data from the perioperative period. Data are
mean (range), mean (SD) or number of patients
Group M (n=30) Group S (n=30)
Sex (M/F) 17/13 15/15
Age (yr) 61 (52–78) 63 (58–75)
Ht (cm) 161.7 (10.0) 164.2 (9.0)
Wt (kg) 57.9 (11.1) 59.6 (11.2)
Amount of fluids during surgery
Crystalloid (ml) 1780 (620) 1670 (970)
Colloids (ml) 530 (93) 493 (82)
Packed red blood cells (ml) 110 (50) 103 (90)
Blood loss during surgery (ml) 259 (83) 238 (92)
Urine output during surgery (ml) 277 (69) 318 (124)
Intraoperative ephedrine use (mg) 5.7 (5.1) 5.8 (5.8)
Duration of surgery (min) 146.0 (17.3) 151.7 (27.4)
Duration of anaesthesia (min) 173.0 (19.5) 176.7 (27.3)
Table 3 Postoperative visual analogue scale (VAS) pain score and side-effects
in the postanaesthetic care unit (PACU), and on postoperative days (PODs) 1 and
2. Values are mean (SD) or the number of patients. The incidence of pruritus was
significantly higher in Group M than in Group S on POD 1 (P=0.012). The
incidence of nausea and vomiting (PONV) was also significantly higher in
Group M group than in Group S on POD 1 (P=0.021)
Group M (n=30) Group S (n=30)
VAS-resting
PACU 23.3 (10.9) 22.7 (9.8)
POD 1 16.7 (7.6) 17.3 (7.8)
POD 2 14.0 (5.0) 14.7 (6.8)
VAS-coughing
POD 1 19.0 (7.6) 20.3 (8.1)
POD 2 15.3 (5.1) 16.0 (7.2)
Pruritus
PACU 1 0
POD 1 8 1
POD 2 2 2
PONV
PACU 0 0
POD 1 9 1
POD 2 2 0
Hypotension
PACU 2 1
POD 1 0 0
POD 2 0 0
Table 4 Number of patients with micturition problems. The number of patients
with serious to major micturition problems in Group S group was significantly
less than that in Group M group on POD 1 and POD 2
Group M
(n=30)
Group S
(n=30)
P-value
POD 1 none/minor/
serious/major
6/11/12/1 26/4/0/0 <0.001
POD 2 none/minor/
serious/major
10/19/0/1 27/3/0/0 <0.001
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suggested the spinal action of morphine was because of the
rapid onset of detrusor relaxation after epidural morphine
administration. Regardless of the mechanism, urinary
retention is one of the side-effects of epidural opioids.
The pharmacokinetics of an epidurally administered drug
has been a subject of much discussion. The site of action of
epidurally administered lipophilic opioids is under debate.
Some studies report that epidurally administered lipophilic
opioids such as alfentanil, sufentanil and fentanyl produce
their effects mostly via systemic mechanism and little via
spinal mechanism.11–15 Bernards and colleagues11 measured
drug concentration in each compartment after epidural
administration of different opioids and reported that in
the epidural space, lipophilic drugs had negligible access
to the spinal cord; thus had less bioavailability because of
possible sequestration, and/or rapid vascular uptake from
the epidural space. However, this does not indicate that the
action of lipophilic opioids on the spinal cord is not the
predominant one. Other studies on epidural fentanyl or
sufentanil after thoracotomy report that thoracic epidural
administration of lipophilic opioids show superior analgesic
effect when compared with that in lumbar epidural
space.16–18 Hansdottir and colleagues16 17 19 published a
series of studies on epidural sufentanil infusion after thora-
cotomy. They demonstrated that concentrations of epidural
sufentanil were higher in CSF than in plasma and that
sufentanil was highly localized in CSF to the level of
administration both after single bolus and infusion.16 19
They also proved in a clinical study that after thoracotomy,
epidural sufentanil analgesia was optimal when tailored
to the site of nociceptive input and combined with bupiva-
caine.17 These data support dermatomal restriction of
lipophilic opioids, which allows reduction in the drug
amount to be administered. In this study, epidural catheters
were inserted at the T7–8 interspace, which corresponds to
the surgical incision site but not associated with detrusor
activity. Therefore, probably both systemic absorption
and dermatomal restriction of epidural sufentanil caused
the reduction in micturition problem during epidurally
administered sufentanil.
The concentration of sufentanil used in this study
(0.9 mg ml1) was based on other studies, in which the
dose ranged from 0.5 to 1 mg ml1 for major abdominal
surgical pain.20–22 The equianalgesic concentration of epi-
dural opioids used in this study was based on the recom-
mended 50 mg ml1 for epidural morphine and 1–2 mg ml1
for epidural sufentanil to be continuously infused at a rate
of 4–8 ml h1.23
In this study, the opioid was mixed with a local anaes-
thetic, ropivacaine, to reduce the incidence of opioid-related
side-effects and to improve analgesia.24–26 The effects of
neuraxial local anaesthetics on bladder function are different
from those of opioids. A complete absence of urge and
detrusor contractility with spinal anaesthesia was reported
up to recovery of sensation of pinprick in the S2–S3
dermatome, which contains most of the fibres concerned
with the control of the bladder and urethral sphincters.27
As the epidural block was administered at the thoracic
level using segmental technique and the concentration of
the ropivacaine was the same (0.2%) for both groups, this
would not have influenced the result of this study.
Unlike epidural morphine, none of the patients who
received epidural sufentanil had serious and/or major
micturition problems on POD 1 in this study. This result
suggests that urinary catheter inserted in the operating
theatre could be removed in the morning of POD 1. This
may have important clinical implications because routine
catheterization beyond 24 h may increase the risk of sub-
sequent urinary infection and voiding problems.1 2 18
Furthermore, if recently introduced portable ultrasound
scan is available, indwelling urinary catheter may be
removed at the end of the surgery because the ultrasound
is reported to measure bladder volume accurately.28–30
In conclusion, the low incidence of micturition problems
in patients receiving sufentanil in continuous thoracic epi-
dural analgesia suggests that routine bladder catheterization
from POD 1 onwards may not be necessary.
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